000134813 001__ 134813
000134813 005__ 20240229105042.0
000134813 0247_ $$2doi$$a10.1177/1534735417713301
000134813 0247_ $$2pmid$$apmid:28617135
000134813 0247_ $$2ISSN$$a1534-7354
000134813 0247_ $$2ISSN$$a1552-695X
000134813 0247_ $$2altmetric$$aaltmetric:21124264
000134813 037__ $$aDKFZ-2018-00604
000134813 041__ $$aeng
000134813 082__ $$a610
000134813 1001_ $$0P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aZimmer, Philipp$$b0$$eFirst author$$udkfz
000134813 245__ $$aInfluence of Personalized Exercise Recommendations During Rehabilitation on the Sustainability of Objectively Measured Physical Activity Levels, Fatigue, and Fatigue-Related Biomarkers in Patients With Breast Cancer.
000134813 260__ $$aThousand Oaks, Calif.$$bSage$$c2018
000134813 3367_ $$2DRIVER$$aarticle
000134813 3367_ $$2DataCite$$aOutput Types/Journal article
000134813 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1528116302_28264
000134813 3367_ $$2BibTeX$$aARTICLE
000134813 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000134813 3367_ $$00$$2EndNote$$aJournal Article
000134813 520__ $$aOnly one-third of patients with breast cancer reach the recommended activity level of 15 to 25 MET h/wk. The aim of this study was to determine the influence of personalized exercise recommendations during rehabilitation on patients' physical activity level, fatigue, and self-perceived cognitive function as well as on side effect-associated biomarkers.Total metabolic rate, physical activity level, mean MET and steps, fatigue, self-perceived cognitive functioning , and biomarkers (C-reactive protein [CRP], interleukin 6, macrophage migration inhibiting factor [MIF], tumor necrosis factor [TNF]-α, brain-derived neurotrophic factor [BDNF], insulin-like growth factor 1 [IGF1]) were assessed in 60 patients with breast cancer in the aftercare phase before ( t0) and 8 months after ( t1) the intervention. The rehabilitation program consisted of an initial 3-week period and a 1-week stay after 4 months.Paired t-test indicated a statistically significant increase in all activity outcomes from t0 to t1. Patients' mean activity level significantly increased from 14.89 to 17.88 MET h/wk. Fatigue and self-perceived cognitive functioning significantly improved from t0 to t1. CRP levels significantly decreased, and BDNF as well as IGF1 levels significantly increased over time. Correlation analysis revealed statistically significant negative associations between fatigue, physical activity, and markers of inflammation (TNF-α and MIF). Furthermore, significant positive correlations between subjective cognitive functioning and all dimensions of fatigue were observed.The results support the importance of personalized exercise recommendations to increase physical activity levels in patients with breast cancer. Furthermore, the results highlighti an association between physical activity, fatigue, and inflammation.
000134813 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000134813 588__ $$aDataset connected to CrossRef, PubMed,
000134813 7001_ $$aBaumann, Freerk T$$b1
000134813 7001_ $$aOberste, Max$$b2
000134813 7001_ $$aSchmitt, Joachim$$b3
000134813 7001_ $$aJoisten, Niklas$$b4
000134813 7001_ $$aHartig, Philipp$$b5
000134813 7001_ $$aSchenk, Alexander$$b6
000134813 7001_ $$aKuhn, Rafaela$$b7
000134813 7001_ $$aBloch, Wilhelm$$b8
000134813 7001_ $$aReuss-Borst, Monika$$b9
000134813 773__ $$0PERI:(DE-600)2101248-9$$a10.1177/1534735417713301$$gVol. 17, no. 2, p. 306 - 311$$n2$$p306 - 311$$tIntegrative cancer therapies$$v17$$x1552-695X$$y2018
000134813 909CO $$ooai:inrepo02.dkfz.de:134813$$pVDB
000134813 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000134813 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000134813 9141_ $$y2018
000134813 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000134813 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000134813 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINTEGR CANCER THER : 2015
000134813 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000134813 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000134813 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000134813 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000134813 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000134813 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000134813 9201_ $$0I:(DE-He78)G210-20160331$$kG210$$lBewegung, Präventionsforschung und Krebs$$x0
000134813 980__ $$ajournal
000134813 980__ $$aVDB
000134813 980__ $$aI:(DE-He78)G210-20160331
000134813 980__ $$aUNRESTRICTED